1. G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer
   Junjie Zhao et al, 2021, British Journal of Cancer CrossRef
2. Decreased expression of EFS is correlated with the advanced prostate cancer
   Selda Sertkaya et al, 2015, Tumor Biology CrossRef
3. FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
   Courtney A. Bartel et al, 2016, Oncotarget CrossRef
4. FAM83D, a microtubule-associated protein, promotes tumor growth and progression of human gastric cancer
   Minlu Huang et al, 2017, Oncotarget CrossRef
5. The FBXW7-binding sites on FAM83D are potential targets for cancer therapy
   Xiaoyu Jiang et al, 2024, Breast Cancer Research CrossRef
6. Upregulation ofFAM83Daffects the proliferation and invasion of hepatocellular carcinoma
   Weijia Liao et al, 2015, Oncotarget CrossRef
7. ABCG2 is a potential marker of tumor-initiating cells in breast cancer
   Renata Danielle Sicchieri et al, 2015, Tumor Biology CrossRef
8. Inhibition of FAM83D displays antitumor effects in glioblastoma via down‐regulation of the AKT/Wnt/β‐catenin pathway
   Jubo Wang et al, 2022, Environmental Toxicology CrossRef
9. Fam83d modulates MAP kinase and AKT signaling and is induced during neurogenic skeletal muscle atrophy
   Lisa M. Cooper et al, 2020, Cellular Signalling CrossRef
10. Dynamic expression of FAM83D in peripheral organs at different ages in mice
    Qixian Li et al, 2021, Gene Expression Patterns CrossRef
11. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway
    Yu Mu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
12. Identification of New Genes Downregulated in Prostate Cancer and Investigation of Their Effects on Prognosis
    Lokman Varisli, 2013, Genetic Testing and Molecular Biomarkers CrossRef
13. Prognostic significance of FAM83D gene expression across human cancer types
    Peter J. Walian et al, 2016, Oncotarget CrossRef
14. FAM83D: Negative regulator for glioma cell proliferation and inadequate indicator for the prognosis of gliomas
    Demin Du et al, 2024, Gene Reports CrossRef
15. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma
    Xuling Liu et al, 2019, Bioscience Reports CrossRef